« Return to News | CROs/Service Providers

Theorem partners with Emergo for regulatory consulting

Tuesday, July 9, 2013 03:06 PM

CRO Theorem Clinical Research, based in King of Prussia, Penn., has formed a strategic partnership with Emergo Group to provide global regulatory consulting services, including reimbursement consultation and in-country regulatory representation services, to the medical device and in vitro diagnostics community. 

“Emergo Group complements our own global strategic regulatory affairs and clinical trial capabilities,” said D. Lee Spurgin Jr., Ph.D., Theorem’s senior vice president and general manager of medical device and diagnostic development. “Working together we can provide more services and a bigger global footprint, so our strategic relationship helps us to be a one-stop provider for our clients.”

Emergo Group is a regulatory consultancy with more than 2,500 medical device and in vitro diagnostic device (IVD) clients and offers a range of compliance and market access services in 25 countries, including global regulatory strategy, device registration, quality management system compliance, in-country regulatory representation and distributor qualification.

With offices in more than 30 countries worldwide, Theorem Clinical Research specializes in the management of complex clinical trials for biopharmaceuticals, medical devices and drug-device combination products.

“The right strategic relationship strengthens both companies,” said Emergo Group president and CEO Rene van de Zande. “We believe the synergy we achieve with Theorem is a benefit to all concerned.”  

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.